Annual Shareholders Equity
$6.89 M
-$11.74 M-63.02%
31 December 2023
Summary:
Aileron Therapeutics annual stockholders equity is currently $6.89 million, with the most recent change of -$11.74 million (-63.02%) on 31 December 2023. During the last 3 years, it has fallen by -$5.28 million (-43.37%). ALRN annual shareholders equity is now -85.59% below its all-time high of $47.80 million, reached on 31 December 2017.ALRN Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$50.23 M
-$5.79 M-10.33%
30 September 2024
Summary:
Aileron Therapeutics quarterly stockholders equity is currently $50.23 million, with the most recent change of -$5.79 million (-10.33%) on 30 September 2024. Over the past year, it has increased by +$39.03 million (+348.54%). ALRN quarterly shareholders equity is now -18.22% below its all-time high of $61.42 million, reached on 31 March 2021.ALRN Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALRN Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -63.0% | +348.5% |
| 3 y3 years | -43.4% | +0.2% |
| 5 y5 years | -64.9% | +120.1% |
ALRN Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -84.3% | at low | -10.3% | +629.3% |
| 5 y | 5 years | -84.3% | at low | -18.2% | +629.3% |
| alltime | all time | -85.6% | +106.2% | -18.2% | +141.6% |
Aileron Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $50.23 M(-10.3%) |
| June 2024 | - | $56.02 M(+25.2%) |
| Mar 2024 | - | $44.75 M(+549.8%) |
| Dec 2023 | $6.89 M(-63.0%) | $6.89 M(-38.5%) |
| Sept 2023 | - | $11.20 M(-12.5%) |
| June 2023 | - | $12.79 M(-10.4%) |
| Mar 2023 | - | $14.27 M(-23.4%) |
| Dec 2022 | $18.62 M(-57.6%) | $18.62 M(-17.9%) |
| Sept 2022 | - | $22.70 M(-20.7%) |
| June 2022 | - | $28.62 M(-20.7%) |
| Mar 2022 | - | $36.11 M(-17.8%) |
| Dec 2021 | $43.90 M(+261.0%) | $43.90 M(-12.4%) |
| Sept 2021 | - | $50.11 M(-10.7%) |
| June 2021 | - | $56.13 M(-8.6%) |
| Mar 2021 | - | $61.42 M(+405.0%) |
| Dec 2020 | $12.16 M | $12.16 M(-2.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2020 | - | $12.46 M(-25.2%) |
| June 2020 | - | $16.65 M(+70.5%) |
| Mar 2020 | - | $9.77 M(-39.1%) |
| Dec 2019 | $16.05 M(-18.1%) | $16.05 M(-29.7%) |
| Sept 2019 | - | $22.82 M(-23.9%) |
| June 2019 | - | $29.98 M(+133.4%) |
| Mar 2019 | - | $12.85 M(-34.5%) |
| Dec 2018 | $19.60 M(-59.0%) | $19.60 M(-24.7%) |
| Sept 2018 | - | $26.03 M(-20.8%) |
| June 2018 | - | $32.87 M(-19.8%) |
| Mar 2018 | - | $40.98 M(-14.3%) |
| Dec 2017 | $47.80 M(-142.7%) | $47.80 M(-11.5%) |
| Sept 2017 | - | $54.01 M(-144.7%) |
| June 2017 | - | -$120.78 M(-945.8%) |
| Mar 2017 | - | $14.28 M(-112.8%) |
| Dec 2016 | -$111.81 M(+18.5%) | -$111.81 M |
| Dec 2015 | -$94.32 M | - |
FAQ
- What is Aileron Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Aileron Therapeutics?
- What is Aileron Therapeutics annual shareholders equity year-on-year change?
- What is Aileron Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Aileron Therapeutics?
- What is Aileron Therapeutics quarterly shareholders equity year-on-year change?
What is Aileron Therapeutics annual stockholders equity?
The current annual shareholders equity of ALRN is $6.89 M
What is the all time high annual shareholders equity for Aileron Therapeutics?
Aileron Therapeutics all-time high annual stockholders equity is $47.80 M
What is Aileron Therapeutics annual shareholders equity year-on-year change?
Over the past year, ALRN annual stockholders equity has changed by -$11.74 M (-63.02%)
What is Aileron Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of ALRN is $50.23 M
What is the all time high quarterly shareholders equity for Aileron Therapeutics?
Aileron Therapeutics all-time high quarterly stockholders equity is $61.42 M
What is Aileron Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, ALRN quarterly stockholders equity has changed by +$39.03 M (+348.54%)